MOUNTAIN VIEW, Calif., Jan 21, 2009 - Omnicell, Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, will hold a conference call Thursday, January 29 to discuss the Company's fourth quarter 2008 financial...

ORLANDO, Fla., Dec 08, 2008 /PRNewswire-FirstCall via COMTEX News Network/ - ASHP Midyear Clinical Meeting and Exhibition - Omnicell, Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, today announced...

MOUNTAIN VIEW, Calif., Nov 26, 2008 /PRNewswire-FirstCall via COMTEX News Network/ - Omnicell, Inc., (Nasdaq: OMCL) a leading provider of system solutions to acute healthcare facilities, today announced that it has attained Gold Certified Partner...

Omnicell Announces Third Quarter 2008 Results MOUNTAIN VIEW, Calif. – October 23, 2008 – Omnicell, Inc. (NASDAQ: OMCL), a leading provider of system solutions to acute healthcare facilities, today announced results for its quarter ended September...

Omnicell Reports Fourth Quarter and Full-Year 2007 Results MOUNTAIN VIEW, Calif. – January 31, 2008 – Omnicell, Inc. (NASDAQ: OMCL), a leading provider of system solutions to acute healthcare facilities, today announced results for its fourth...

The first sentence of the second paragraph of the release dated Feb. 15, 2023, has been corrected to replace the dial-in numbers for the earnings call on Tuesday, February 28, 2023. The updated release reads: OMNICELL TO RELEASE FOURTH QUARTER AND...

2022 Total Bookings of $1.054 billion Full Year 2022 GAAP Revenues of $1.296 and non-GAAP Revenues of $1.297 billion Ended Year with Over 150 Long-Term, Sole-Source Agreements with the Top 300 U.S. Health Systems Year End 2022 Backlog of $1.215...

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter 2023 after market close on Tuesday, May 2, 2023....

Total GAAP revenues of $291 million GAAP net loss per diluted share of $0.33 Non-GAAP net income per diluted share of $0.39 Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the...

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, announced that it will present at the BofA Securities 2023 Healthcare Conference on Thursday, May 11, 2023 at 8:00 a.m. PT. Live...

Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced changes to its leadership structure designed to create a more streamlined organization with a continued focus on...

Omnicell, Inc. , ( NASDAQ : OMCL), today announced it is realigning its organization to continue its growth strategy of offering differentiated products, expanding into new markets and increasing its presence through acquisitions. Over the past...

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced that Peter Kuipers has joined the company as Executive Vice President, Chief Financial Officer. Mr. Kuipers brings...

Omnicell, Inc. (NASDAQ:OMCL) today announced that LCMC Health has selected Omnicell medication dispensing technology for their newest state-of-the-art facility, the University Medical Center New Orleans (UMC New Orleans), which hopes to better serve...

Omnicell, Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, will hold a conference call Monday, April 26 to discuss the Company's First Quarter 2010 financial results. Omnicell First Quarter 2010 earnings...

MOUNTAIN VIEW, Calif., Dec 17, 2009 /PRNewswire-FirstCall via COMTEX News Network/ - Omnicell, Inc ., (Nasdaq: OMCL) a leading provider of medication system solutions to acute healthcare facilities, today announced that CoxHealth, a Top 100...